Premium
Initial Clinical Experiences With Novel Diagonal ECLS System in Pediatric Cardiac Patients
Author(s) -
Okan Yildiz,
Sertac Haydin,
Erkut Ozturk,
Taner Kasar,
Selen Onan I.,
Firat Altin H.,
Nihat Cine,
Pelin Ayyildiz,
Halime Erkan,
Alper Guzeltas
Publication year - 2017
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1111/aor.12977
Subject(s) - medicine , extracorporeal , extracorporeal membrane oxygenation , cardiac surgery , weaning , life support , statistical significance , heart failure , surgery , cardiology , intensive care medicine
Extracorporeal life support (ECLS) provides mechanical support following cardiac surgery when respiratory or cardiac failure occurs. The aim of this study was to analyze the safety and feasibility of the Medos Deltastream diagonal pump (DP3) ECLS system in pediatric cardiac patients. We described the technical considerations and risk factors related to the survival outcomes in 102 pediatric cardiac patients who received ECLS support between March 2011 and April 2016. We switched from the DP2 system, which was used for the initial 25 patients, to the DP3 system after November 2012. The DP3 was then used in a consecutive series of 77 patients (4.5% of all pediatric patients who underwent congenital heart surgery during the same time period). The patients’ median age was 90 days (range: 2 days–12 years), while their median weight was 4 kg (range: 2.1–40 kg). Fifty four patients (70%) were weaned off ECLS, while 28 patients (36.3%) were successfully discharged from the hospital by means of the DP3 system. The median ECLS duration for survivors was 8.2 days (range: 4–14.5 days). The ECLS indications, durations, and initiation times had no statistical significance in terms of survival. Renal, hemorrhagic, and neurologic complications were all associated with decreased hospital discharge rates ( P = 0.003, P = 0.045, and P < 0.001 respectively). Higher lactate levels ( P = 0.009) and longer duration for normalization ( P < 0.001) were both associated to failure to wean off ECLS support and, hence, to hospital deaths. The weaning rate was 36% prior to November 2012. It increased to 70.3% after that time ( P = 0.009). The mechanical complication rate was 9% with the DP3 system and 32% with the DP2, which was statistically significant ( P = 0.009). Additionally, the lactate levels were higher and decreased more slowly in the patients supported by the DP2. As a result of the shift to the DP3 system, a revised ECLS protocol, and increased ECLS experience, a significant improvement was observed in our clinical outcomes. The results of this study suggested that the combination of a DP3 pump and a Hilite oxygenator in pediatric ECLS circuits may improve durability and reduce circuit‐induced complications.